Drugs / sylibin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02633696 Comparator | Oct → Nov 2013 | — | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sylibin | “350 mg iv of sylibin lyophilisate for solution for infusion (legalon sil) in two hours (single dose)” NCT02633696 ↗ |
| Route | Intravenous | “350 mg iv of sylibin lyophilisate for solution for infusion” NCT02633696 ↗ |